Growth and Yield Responses of Mungbean Accessions to Salinity Stress and Their Nodulation Ability
Plant and Crop Letters · 05.04.2025
DOI: 10.65822/j.pcl/2025.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Plant and Crop Letters, online erschienen am 05.04.2025.
Abstract (Originalsprache)
Salinity is a major constraint on mungbean (Vigna radiata) production, but genetic variation in tolerance offers opportunities for crop improvement.This study evaluated the growth, nodulation, and yield responses of 16 mungbean accessions under control (0 mM) and saline (200 mM NaCl) conditions using a factorial split-plot design with three replications.Plant height, leaf number, root length, shoot fresh weight, shoot dry weight, number and effectiveness of nodules, and seed yield were measured.Salinity significantly reduced all measured traits, with mean decreases of 34% in plant height, 42% in root length, 49% in shoot dry weight, 58% in nodule number, and 57% in seed yield.However, accessions 1, 4, 8, and 19 showed markedly better performance under salinity, retaining higher vegetative growth, biomass, nodulation, and seed yield than other accessions.These results indicate that genetic variability exists for salinity tolerance in mungbean and that nodulation performance is a useful indicator of tolerance.The identified accessions can serve as genetic resources for breeding salt-tolerant mungbean varieties to improve productivity and nitrogen fixation in saline-affected areas.
Zitieren
APA
(2025). Growth and Yield Responses of Mungbean Accessions to Salinity Stress and Their Nodulation Ability. Plant and Crop Letters. https://doi.org/10.65822/j.pcl/2025.12
Vancouver
Growth and Yield Responses of Mungbean Accessions to Salinity Stress and Their Nodulation Ability. Plant and Crop Letters. 2025. doi:10.65822/j.pcl/2025.12
BibTeX
@article{euvimed2025,
title = {Growth and Yield Responses of Mungbean Accessions to Salinity Stress and Their Nodulation Ability},
journal = {Plant and Crop Letters},
year = {2025},
doi = {10.65822/j.pcl/2025.12}
}
EUVIMED